RFP
CORT icon

Root Financial Partners’s Corcept Therapeutics CORT Stock Holding History

Root Financial Partners’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81 Sell
2
-162
-99% -$6.06K ﹤0.01% 3314
2025
Q4 		$5.71K Sell
164
-38
-19% -$2.98K ﹤0.01% 1722
2025
Q3 		$16.8K Buy
+202
New +$14.6K ﹤0.01% 1205

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Root Financial Partners's CORT Position: Q1 2026 in Review

Root Financial Partners reduced its Corcept Therapeutics (CORT) stake by 99% in Q1 2026, selling an estimated $6.06K and leaving 2 shares worth $81. The position accounts for ﹤0.01% of the portfolio, ranked #3314.

Root Financial Partners first reported a position in CORT in Q3 2025 and has held it in 3 quarters since. The position peaked at $16.8K in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Root Financial Partners held 2 shares of Corcept Therapeutics worth $81 as of Q1 2026.
  • Root Financial Partners sold 162 Corcept Therapeutics shares in Q1 2026, an estimated $6.06K.
  • Corcept Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #3314 holding.
  • Root Financial Partners first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Root Financial Partners's Corcept Therapeutics position peaked at $16.8K in Q3 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.